Your browser doesn't support javascript.
loading
Identifying multiscale translational safety biomarkers using a network-based systems approach.
Callegaro, Giulia; Schimming, Johannes P; Piñero González, Janet; Kunnen, Steven J; Wijaya, Lukas; Trairatphisan, Panuwat; van den Berk, Linda; Beetsma, Kim; Furlong, Laura I; Sutherland, Jeffrey J; Mollon, Jennifer; Stevens, James L; van de Water, Bob.
Afiliação
  • Callegaro G; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research (LACDR), Leiden University, Leiden, the Netherlands.
  • Schimming JP; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research (LACDR), Leiden University, Leiden, the Netherlands.
  • Piñero González J; Hospital del Mar Research Institute (IMIM), Pompeu Fabra University (UPF), Barcelona, Spain.
  • Kunnen SJ; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research (LACDR), Leiden University, Leiden, the Netherlands.
  • Wijaya L; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research (LACDR), Leiden University, Leiden, the Netherlands.
  • Trairatphisan P; AbbVie Deutschland GmbH & Co KG, Ludwigshafen, Germany.
  • van den Berk L; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research (LACDR), Leiden University, Leiden, the Netherlands.
  • Beetsma K; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research (LACDR), Leiden University, Leiden, the Netherlands.
  • Furlong LI; Hospital del Mar Research Institute (IMIM), Pompeu Fabra University (UPF), Barcelona, Spain.
  • Sutherland JJ; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Mollon J; AbbVie Deutschland GmbH & Co KG, Ludwigshafen, Germany.
  • Stevens JL; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research (LACDR), Leiden University, Leiden, the Netherlands.
  • van de Water B; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research (LACDR), Leiden University, Leiden, the Netherlands.
iScience ; 26(3): 106094, 2023 Mar 17.
Article em En | MEDLINE | ID: mdl-36895646
ABSTRACT
Animal testing is the current standard for drug and chemicals safety assessment, but hazards translation to human is uncertain. Human in vitro models can address the species translation but might not replicate in vivo complexity. Herein, we propose a network-based method addressing these translational multiscale problems that derives in vivo liver injury biomarkers applicable to in vitro human early safety screening. We applied weighted correlation network analysis (WGCNA) to a large rat liver transcriptomic dataset to obtain co-regulated gene clusters (modules). We identified modules statistically associated with liver pathologies, including a module enriched for ATF4-regulated genes as associated with the occurrence of hepatocellular single-cell necrosis, and as preserved in human liver in vitro models. Within the module, we identified TRIB3 and MTHFD2 as a novel candidate stress biomarkers, and developed and used BAC-eGFPHepG2 reporters in a compound screening, identifying compounds showing ATF4-dependent stress response and potential early safety signals.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article